Publications by authors named "Martin Homering"

Claim this Profile
C
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
Gunnar Brobert, Ana Ruigomez, Tania Schink, Annemarie Voss, Ron Herings, Martin Homering

BMJ Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
Paolo Prandoni, Anthonie W A Lensing, Martin H Prins, Martin Gebel, Akos F Pap, Martin Homering

Thromb Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrent venous thromboembolism according to baseline risk factor profiles.
Martin H Prins, Anthonie W A Lensing, Paolo Prandoni, Philip S Wells, Peter Verhamme, Martin Homering

Blood Adv· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Bennett Levitan, Zhong Yuan, Alexander G G Turpie, Richard J Friedman, Martin Homering

Vasc Health Risk Manag· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty.
Richard Friedman, Martin Homering, Gerlind Holberg, Scott D Berkowitz

J Bone Joint Surg Am· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complication rates after hip or knee arthroplasty in morbidly obese patients.
Richard J Friedman, Susanne Hess, Scott D Berkowitz, Martin Homering

Clin Orthop Relat Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Bengt I Eriksson, Nadia Rosencher, Richard J Friedman, Martin Homering, Ola E Dahl

Thromb Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
Danny M Cohn, Jeroen Hermanides, J Hans DeVries, Pieter-Willem Kamphuisen, Silvia Kuhls, Martin Homering

Thromb Haemost· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
Alexander G G Turpie, Michael Rud Lassen, Bengt I Eriksson, Michael Gent, Scott D Berkowitz, Martin Homering

Thromb Haemost· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
William D Fisher, Bengt I Eriksson, Kenneth A Bauer, Lars Borris, Ola E Dahl, Martin Homering

Thromb Haemost· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment.
Raymond C Rosen, William A Fisher, Manfred Beneke, Martin Homering, Thomas Evers

BJU Int· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil restores erectile function to normal range in men with erectile dysfunction.
Harin Padma-Nathan, Francesco Montorsi, François Giuliano, Eric Meuleman, Stephen Auerbach, Martin Homering

J Sex Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil in patients with erectile dysfunction: achieving treatment optimization.
Wayne J G Hellstrom, Mostafa Elhilali, Martin Homering, Terry Taylor, Marc Gittleman

J Androl· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
Luc Valiquette, Francesco Montorsi, Wayne J G Hellstrom, Francois Giuliano, Martin Homering

Can J Urol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age.
François Giuliano, Craig Donatucci, Francesco Montorsi, Stephen Auerbach, Gary Karlin, Martin Homering

BJU Int· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil provides reliable efficacy over time in men with erectile dysfunction.
Francesco Montorsi, Wayne J G Hellstrom, Luc Valiquette, Martin Bastuba, Owen Collins, Martin Homering

Urology· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
Craig Donatucci, Ian Eardley, Jacques Buvat, Marc Gittelman, Phillip Kell, Martin Homering

J Sex Med· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis